We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
1226
Iovance Biotherapeutics
IOVA
$3.65B
$131K ﹤0.01%
16,279
+1,873
+13% +$20.1K
DCH
1227
Dauch Corp
DCH
$1.51B
$127K ﹤0.01%
18,225
+2,800
+18% +$20.6K
JBLU icon
1228
JetBlue
JBLU
$1.85B
$118K ﹤0.01%
19,424
-1,062
-5% -$6.4K
ARDX icon
1229
Ardelyx
ARDX
$973M
$116K ﹤0.01%
15,609
+824
+6% +$5.79K
DRH icon
1230
Diamondrock Hospitality Co
DRH
$2.6B
$112K ﹤0.01%
13,289
+568
+4% +$4.95K
SAN icon
1231
Banco Santander
SAN
$214B
$112K ﹤0.01%
24,184
+4,532
+23% +$22.3K
ADT icon
1232
ADT
ADT
$5.51B
$112K ﹤0.01%
14,716
+1,174
+9% +$8.13K
HLMN icon
1233
Hillman Solutions
HLMN
$1.53B
$110K ﹤0.01%
12,375
+457
+4% +$4.31K
MPT
1234
Medical Properties Trust
MPT
$2.44B
$110K ﹤0.01%
25,406
-3,210
-11% -$15.4K
RKLB icon
1235
Rocket Lab Corp
RKLB
$42B
$106K ﹤0.01%
22,185
+4,997
+29% +$20.8K
TDOC icon
1236
Teladoc Health
TDOC
$1.18B
$105K ﹤0.01%
+10,745
New +$131K
CORZ icon
1237
Core Scientific
CORZ
$5.48B
$104K ﹤0.01%
+11,202
New +$57.2K
DNB
1238
DELISTED
Dun & Bradstreet
DNB
$100K ﹤0.01%
+10,820
New +$104K
PAYO icon
1239
Payoneer
PAYO
$2.42B
$99.3K ﹤0.01%
17,928
+1,942
+12% +$10.5K
RXRX icon
1240
Recursion Pharmaceuticals
RXRX
$1.81B
$98.5K ﹤0.01%
+13,132
New +$115K
NWL icon
1241
Newell Brands
NWL
$2.61B
$97.8K ﹤0.01%
15,263
+1,216
+9% +$9.05K
MFG icon
1242
Mizuho Financial
MFG
$130B
$97.6K ﹤0.01%
23,063
+4,041
+21% +$16K
BORR
1243
Borr Drilling
BORR
$1.36B
$97.1K ﹤0.01%
15,058
+1,767
+13% +$10.7K
WIT icon
1244
Wipro
WIT
$18B
$96.8K ﹤0.01%
31,732
+5,664
+22% +$15.6K
VIAV icon
1245
Viavi Solutions
VIAV
$9.32B
$96.3K ﹤0.01%
14,011
+515
+4% +$4K
PLUG icon
1246
Plug Power
PLUG
$3.09B
$93.3K ﹤0.01%
40,035
+21,707
+118% +$62.2K
GNL icon
1247
Global Net Lease
GNL
$2.13B
$93.2K ﹤0.01%
12,680
+956
+8% +$6.93K
IONQ icon
1248
IonQ
IONQ
$16.2B
$88.1K ﹤0.01%
+12,532
New +$103K
AMC icon
1249
AMC Entertainment Holdings
AMC
$2.41B
$88.1K ﹤0.01%
+17,683
New +$71K
NMR icon
1250
Nomura Holdings
NMR
$30.1B
$87.9K ﹤0.01%
15,200
+2,615
+21% +$15.5K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.